. Author manuscript; available in PMC: 2019 Mar 1.

Published in final edited form as: J Am Acad Dermatol. 2017 Oct 5;78(3):490–497.e1. doi: 10.1016/j.jaad.2017.09.062

Table 3.

Univariate analysis of overall and disease-specific survival.

	Overall		Disease-Specific
Characteristic	HR (95% CI)	P Value for Log Rank	HR (95% CI)	P Value for Log Rank
Overall^a
Year of diagnosis (Advanced)	1.00 (0.98–1.03)	0.98	1.02 (0.99–1.05)	0.43
Age (Advanced)	1.04 (1.02–1.06)	<0.01	1.03 (1.01–1.06)	<0.01
Sex (Male)	0.82 (0.42–1.57)	0.36	0.50 (0.22–1.10)	0.06
Race (Black)	1.91 (1.00–3.70)	0.04	1.23 (0.57–2.65)	0.56
Residency demographic (Metro)	0.28 (0.10–0.80)	0.05	0.45 (0.16–1.27)	0.12
Stage (Advanced)	1.84 (1.40–2.41)	<0.01	2.08 (1.56–2.77)	<0.01
Body site (Pelvis)	1.00 (Reference)	<0.01	1.00 (Reference)	<0.01
Face	0.24 (0.07–0.85)		0.14 (0.03–0.70)
Trunk	0.26 (0.10–0.73)		0.32 (0.12–0.88)
Upper Limb	0.25 (0.08–0.76)		0.20 (0.06–0.66)
Lower Limb	0.33 (0.12–0.94)		0.36 (0.13–1.03)
Surgery (Performed)	0.32 (0.16–0.67)	<0.01	0.23 (0.11–0.48)	<0.01
Radiation therapy (None)	0.25 (0.11–0.56)	<0.01	0.26 (0.12–0.58)	<0.01